Chemoinformaics analysis of 4-Hydroxy-2-isopropenyl-5-methylhex-5-enyl 2-methylbutyrate
Molecular Weight | 254.37 | nRot | 8 |
Heavy Atom Molecular Weight | 228.162 | nRig | 3 |
Exact Molecular Weight | 254.188 | nRing | 0 |
Solubility: LogS | -2.615 | nHRing | 0 |
Solubility: LogP | 3.09 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 44.7926 |
nHD | 1 | BPOL | 28.6874 |
QED | 0.535 |
Synth | 4 |
Natural Product Likeliness | 1.638 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.012 |
HIA | 0.009 |
CACO-2 | -4.378 |
MDCK | 0.0000199 |
BBB | 0.401 |
PPB | 0.520135 |
VDSS | 1.153 |
FU | 0.525348 |
CYP1A2-inh | 0.064 |
CYP1A2-sub | 0.154 |
CYP2c19-inh | 0.033 |
CYP2c19-sub | 0.842 |
CYP2c9-inh | 0.016 |
CYP2c9-sub | 0.268 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.545 |
CYP3a4-inh | 0.044 |
CYP3a4-sub | 0.341 |
CL | 11.12 |
T12 | 0.347 |
hERG | 0.038 |
Ames | 0.013 |
ROA | 0.034 |
SkinSen | 0.061 |
Carcinogencity | 0.125 |
EI | 0.46 |
Respiratory | 0.851 |
NR-Aromatase | 0.007 |
Antiviral | Yes |
Prediction | 0.772382 |